APOL1 genotyping of African American deceased organ donors: Not just yet

American Journal of Transplantation

Volumn 15, Issue 6, 2015, Pages 1457-1458

  Ojo, A ^a   Knoll, G A ^b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; ALLELE; APOLIPOPROTEIN L1 GENE; CADAVER DONOR; DISEASE COURSE; EDITORIAL; END STAGE RENAL DISEASE; FOLLOW UP; GENE; GENETIC RESISTANCE; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PHENOTYPE; PRIORITY JOURNAL; DONOR; FEMALE; GENETIC VARIATION; GENETICS; GRAFT REJECTION; KIDNEY DISEASES; MALE;

APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN;

AFRICAN AMERICANS; APOLIPOPROTEINS; FEMALE; GENETIC VARIATION; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIPOPROTEINS, HDL; MALE; TISSUE DONORS;

EID: 84929321287     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13230     Document Type: Editorial

References (5)

1. Genovese G, Friedman DJ, Ross MD, et al., Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845.
2. Parsa A, Kao WH, Xie D, et al., AppelLJ, AASK study investigators; CRIC study investigators. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med 2013; 369: 2183-2196.
3. Lee BT, Kumar V, Williams TA, et al., The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival. Am J Transplant 2012; 12: 1924-1928.
4. Reeves-Daniel AM, Depalma JA, Bleyer AJ, et al., The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant 2011; 11: 1025-1030.
5. Freedman BI, Julian BA, Pastan SO, et al., Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Am J Transplant 2015; 15: 1615-1622.